Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (211-220 of 447) with videos related to

Pageof 45
Sort By:
Journal for Immunotherapy of Cancer|May 27, 2025
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancerSimone Stucchi, Roberto Borea, Susana Garcia-Recio, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchJames M Haughian, Mauricio P Pinto, J Chuck Harrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2011
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumJustin M Balko, Todd W Miller, Meghan M Morrison, et al.
Breast Cancer Research and Treatment|September 19, 2020
Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatmentJiehui Deng, Aatish Thennavan, Suhagi Shah, et al.
BMC Medicine|December 20, 2015
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyAleix Prat, Cheng Fan, Aranzazu Fernández, et al.
Breast Cancer Research and Treatment|June 25, 2015
CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancerJustin L Black, J Chuck Harrell, Tina M Leisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trialJudith Hugh, John Hanson, Maggie Chon U Cheang, et al.
Cancer Research|May 2, 2013
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signalingChristian D Young, Adam D Pfefferle, Philip Owens, et al.
Cell Stem Cell|May 10, 2011
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cellsAmy N Abell, Nicole Vincent Jordan, Weichun Huang, et al.
The Journal of Clinical Investigation|January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJose V Moyano, Joseph R Evans, Feng Chen, et al.
Pageof 45

Showing results (211-220 of 447) with videos related to

Sort By:
Pageof 45
Journal for Immunotherapy of Cancer|May 27, 2025
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancerSimone Stucchi, Roberto Borea, Susana Garcia-Recio, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchJames M Haughian, Mauricio P Pinto, J Chuck Harrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2011
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumJustin M Balko, Todd W Miller, Meghan M Morrison, et al.
Breast Cancer Research and Treatment|September 19, 2020
Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatmentJiehui Deng, Aatish Thennavan, Suhagi Shah, et al.
BMC Medicine|December 20, 2015
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyAleix Prat, Cheng Fan, Aranzazu Fernández, et al.
Breast Cancer Research and Treatment|June 25, 2015
CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancerJustin L Black, J Chuck Harrell, Tina M Leisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trialJudith Hugh, John Hanson, Maggie Chon U Cheang, et al.
Cancer Research|May 2, 2013
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signalingChristian D Young, Adam D Pfefferle, Philip Owens, et al.
Cell Stem Cell|May 10, 2011
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cellsAmy N Abell, Nicole Vincent Jordan, Weichun Huang, et al.
The Journal of Clinical Investigation|January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJose V Moyano, Joseph R Evans, Feng Chen, et al.
Pageof 45